Namodenoson

未知生产厂商

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TREATMENT OF PANCREATIC CANCER
EP 4654977 A1申请人: CAN FITE BIOPHARMA LTD优先权: 2023
EP
US
WO
3 件公开
PROCESS FOR PREPARING NAMODENOSON
US 20250368676 A1申请人: CAN FITE BIOPHARMA LTD优先权: 2024
US
WO
2 件公开
A3 adenosine receptors for treating diseases associated with OCRL gene dysfunction
CN 121666237 A申请人: FOND TELETHON优先权: 2023
CN